Close

Intercept Pharma (ICPT) Misses Q2 EPS by 4c

August 5, 2015 4:20 PM EDT

Intercept Pharma (NASDAQ: ICPT) reported Q2 EPS of ($1.99), $0.04 worse than the analyst estimate of ($1.95). Revenue for the quarter came in at $445 thousand versus the consensus estimate of $2.17 million.

For earnings history and earnings-related data on Intercept Pharma (ICPT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings